The FDA is to review Sanofi/Regeneron's Dupixent as a treatment ... the latest in a new wave of injected therapies, along with GlaxoSmithKline’s Nucala and Teva’s Cinqaero.
Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan. The French pharma in April joined forces with the UK ...
(Reuters) -GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday. The move comes as a multi-state ...